Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Vaderis Forms to Tackle Vascular Malformations with Novartis Vet at the Helm
BioSpace
Mon, 08/22/22 - 10:24 am
Tags:
Vaderis, Novartis, vascular malformations, clinical trials, VAD044
Novartis' MS drug Gilenya could inspire new chronic kidney disease treatment
Fierce Biotech
Fri, 08/19/22 - 10:47 am
Tags:
Novartis, Gilenya, kidney disease, chronic kidney disease
Novartis' former weight loss med Sanorex at center of New Jersey pharma chief's guilty plea
Fierce Pharma
Tue, 08/16/22 - 10:56 am
Tags:
Novartis, Sanorex, weight loss, legal, Alain Bouaziz
Novartis bid to repurpose rare disease drug for cancer falls short in third trial
BioPharma Dive
Mon, 08/15/22 - 10:15 am
Tags:
Novartis, cancer, clinical trials, lung cancer, canakinumab
Novartis reports deaths of two patients treated with Zolgensma gene therapy
BioPharma Dive
Thu, 08/11/22 - 11:32 pm
Tags:
Novartis, gene therapy, Zolgensma, SMA, patient deaths, spinal muscular atrophy
FDA converts Novartis' NSCLC drug to a full approval with confirmatory data
Endpoints
Thu, 08/11/22 - 11:22 pm
Tags:
Novartis, Tabrecta, solid tumors, FDA, non-small cell lung cancer
Novartis tips Lucentis to weather the arrival of biosimilar copies in Europe
Biopharma Reporter
Thu, 08/11/22 - 12:30 pm
Tags:
Novartis, Lucentis, biosimilars, patents, Europe
BeiGene and Novartis Make Late-Stage Progress against Liver Cancer
BioSpace
Tue, 08/9/22 - 12:14 pm
Tags:
Novartis, BeiGene, hepatocellular carcinoma, liver cancer, clinical trials
Novartis, UC Berkeley-spawned startup snags $65M to keep key proteins out of the cell’s trash can
MedCity News
Tue, 08/2/22 - 12:06 am
Tags:
Vicinitas Therapeutics, small molecule drugs, UC Berkley, Novartis
Drugmakers leap back into fading heart drug market
Beckers Hospital Review
Thu, 07/28/22 - 06:40 pm
Tags:
Bristol Myers Squibb, Novartis, Merck, Alnylam Pharmaceuticals, Amgen, hypertension, cholesterol
Biogen, watch out: Novartis' Tysabri biosim application could portend multiple sclerosis showdown in Europe and US
Fierce Pharma
Wed, 07/27/22 - 10:58 am
Tags:
Novartis, Biogen, multiple sclerosis, MS, Tysabri, biosimilars
Novartis fails to win appeal in whistleblower case involving cancer drug study
Endpoints
Tue, 07/26/22 - 05:29 pm
Tags:
Novartis, legal, whistleblowers
Novartis asks FDA to approve biosimilar for Biogen’s top-selling MS drug
BioPharma Dive
Mon, 07/25/22 - 09:54 pm
Tags:
Novartis, FDA, Biogen, biosimilars, Tysabri, MS, multiple sclerosis
What This FDA Delay Means for Novartis
Motley Fool
Thu, 07/21/22 - 10:36 am
Tags:
Novartis, FDA, cancer, tislelizumab
Moving Away from Asthma and COPD, Novartis Hones in on 20 Approvals by 2026
BioSpace
Thu, 07/21/22 - 10:24 am
Tags:
Novartis, asthma, COPD
Novartis Posts Mixed Q2 Earnings, Expects Improved Earnings At Sandoz
Benzinga
Tue, 07/19/22 - 09:56 pm
Tags:
Novartis, earnings
Novartis looking for new homes for midphase asthma, eye disease and NASH assets after pipeline review
Fierce Biotech
Tue, 07/19/22 - 10:36 am
Tags:
Novartis, asthma, NASH, Retinitis pigmentosa
Novartis turns to algorithms developer Anumana to apply AI to cardio conditions
MedCity News
Sun, 07/17/22 - 10:41 pm
Tags:
Novartis, Anumana, artificial intelligence, diagnostics, cardiovascular disease
Ex-Novartis sales rep claims discrimination, retaliation led to her firing after she reported misconduct
Fierce Pharma
Fri, 07/15/22 - 12:21 pm
Tags:
Novartis, retaliation claims, discrimination, drug reps
FDA Indefinitely Delays BeiGene/Novartis anti-PD-1 Esophageal Cancer Drug
BioSpace
Thu, 07/14/22 - 10:51 am
Tags:
Novartis, BeiGene, FDA, tislelizumab, esophageal cancer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.